We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

122 hedge funds and large institutions have $319M invested in Spectrum Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 122 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

38% less call options, than puts

Call options by funds: $3.39M | Put options by funds: $5.49M

Holders
122
Holders Change
+122
Holders Change %
–
% of All Funds
3.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
122
Increased
–
Reduced
–
Closed
–
Calls
$3.39M
Puts
$5.49M
Net Calls
-$2.1M
Net Calls Change
-$2.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$46.5M +$47.9M +6,238,680 New
BFA
2
BlackRock Fund Advisors
California
$27.1M +$27.9M +3,637,843 New
State Street
3
State Street
Massachusetts
$26.4M +$27.2M +3,542,188 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$24.8M +$25.5M +3,318,762 New
Millennium Management
5
Millennium Management
New York
$15.1M +$15.6M +2,028,177 New
Invesco
6
Invesco
Georgia
$14.4M +$14.9M +1,936,614 New
BIT
7
BlackRock Institutional Trust
California
$14.2M +$14.6M +1,900,397 New
FCAM
8
F&C Asset Management
United Kingdom
$11.8M +$12.2M +1,586,882 New
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$9.65M +$9.92M +1,292,991 New
Goldman Sachs
10
Goldman Sachs
New York
$9.61M +$9.89M +1,288,602 New
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$8.97M +$9.22M +1,202,281 New
Barclays
12
Barclays
United Kingdom
$8.1M +$8.33M +1,085,771 New
Wellington Management Group
13
Wellington Management Group
Massachusetts
$7.49M +$7.7M +1,003,467 New
KCM
14
Kennedy Capital Management
Missouri
$7.38M +$7.59M +989,534 New
Northern Trust
15
Northern Trust
Illinois
$6.95M +$7.14M +930,963 New
Morgan Stanley
16
Morgan Stanley
New York
$4.89M +$5.03M +655,244 New
PC
17
PointState Capital
New York
$4.85M +$4.99M +650,000 New
Schroder Investment Management Group
18
Schroder Investment Management Group
United Kingdom
$4.45M +$4.58M +596,781 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$4.41M +$4.53M +591,025 New
PAI
20
Palo Alto Investors
California
$2.95M +$3.04M +395,985 New
PI
21
Putnam Investments
Massachusetts
$2.43M +$2.5M +326,055 New
TCIM
22
TIAA CREF Investment Management
New York
$2.31M +$2.37M +309,267 New
Principal Financial Group
23
Principal Financial Group
Iowa
$2.19M +$2.25M +293,181 New
PP
24
PDT Partners
New York
$2.1M +$2.16M +281,078 New
GC
25
Guggenheim Capital
Illinois
$2.03M +$2.08M +271,734 New
1
2 3 4 5

SPPI Hedge Fund Activity: Q2 2013 in Review

122 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2013, worth a combined $319M.

Buyers outnumbered sellers: 122 funds opened new SPPI positions and 0 closed out — a net gain of 122 holders — while 0 added to existing stakes and 0 trimmed.

  • 122 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $319M of Spectrum Pharmaceuticals Inc stock for Q2 2013.
  • 122 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +122 holders.

Based on aggregated 13F filings for Q2 2013.